These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 25458200

  • 21. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E, Gil Alaña P, Alkiza Basañez R, Hernández Gil A, Garros Garay J, Artola Igarza JL.
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [Abstract] [Full Text] [Related]

  • 22. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
    Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahn SA, Smith LJ, Stewart JO, Abuan T, Tully H, Van Dalfsen J, Wells CD, Quan J.
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):481-5. PubMed ID: 10934074
    [Abstract] [Full Text] [Related]

  • 23. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V, Grimwood K, Byrnes CA, Morris PS, Masters IB, Ware RS, McCallum GB, Binks MJ, Marchant JM, van Asperen P, O'Grady KF, Champion A, Buntain HM, Petsky H, Torzillo PJ, Chang AB.
    Lancet; 2018 Oct 06; 392(10154):1197-1206. PubMed ID: 30241722
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW, Fan LC, Lu HW, Miao XY, Mao B, Xu JF.
    Clin Respir J; 2016 Nov 06; 10(6):731-739. PubMed ID: 25620629
    [Abstract] [Full Text] [Related]

  • 25. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ, Jary HR, Perry A, MacFarlane JG, Hester KL, Small T, Molyneux C, Perry JD, Walton KE, De Soyza A.
    Respir Med; 2015 Jun 06; 109(6):716-26. PubMed ID: 25200914
    [Abstract] [Full Text] [Related]

  • 26. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL.
    N Engl J Med; 1999 Jan 07; 340(1):23-30. PubMed ID: 9878641
    [Abstract] [Full Text] [Related]

  • 27. Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma.
    Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Rogers GB, Simpson JL.
    Am J Respir Crit Care Med; 2019 Aug 01; 200(3):309-317. PubMed ID: 30875247
    [Abstract] [Full Text] [Related]

  • 28. Corrections. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ.
    Lancet Respir Med; 2015 Apr 01; 3(4):e15. PubMed ID: 25890660
    [No Abstract] [Full Text] [Related]

  • 29. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
    Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME.
    Drug Des Devel Ther; 2018 Apr 01; 12():4059-4066. PubMed ID: 30568427
    [Abstract] [Full Text] [Related]

  • 30. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan 01; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.
    Respir Med; 2008 Nov 01; 102(11):1643-53. PubMed ID: 18701270
    [Abstract] [Full Text] [Related]

  • 33. Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition.
    Peleg AY, Choo JM, Langan KM, Edgeworth D, Keating D, Wilson J, Rogers GB, Kotsimbos T.
    J Cyst Fibros; 2018 Jan 01; 17(1):50-56. PubMed ID: 29042177
    [Abstract] [Full Text] [Related]

  • 34. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
    Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A, TOPIC Study Group.
    Lancet; 2018 Jan 01; 365(9459):573-8. PubMed ID: 15708100
    [Abstract] [Full Text] [Related]

  • 35. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V, Bartlett J, Jayaram L.
    Respirology; 2017 Jul 01; 22(5):922-927. PubMed ID: 28236369
    [Abstract] [Full Text] [Related]

  • 36. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
    Bilton D, Daviskas E, Anderson SD, Kolbe J, King G, Stirling RG, Thompson BR, Milne D, Charlton B, B301 Investigators.
    Chest; 2013 Jul 01; 144(1):215-225. PubMed ID: 23429964
    [Abstract] [Full Text] [Related]

  • 37. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Sangiovanni S, Morales EI, Fernández-Trujillo L.
    Respir Med; 2021 Jan 01; 176():106283. PubMed ID: 33307314
    [Abstract] [Full Text] [Related]

  • 38. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
    Nicolson CH, Stirling RG, Borg BM, Button BM, Wilson JW, Holland AE.
    Respir Med; 2012 May 01; 106(5):661-7. PubMed ID: 22349069
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.
    Orriols R, Hernando R, Ferrer A, Terradas S, Montoro B.
    Respiration; 2015 May 01; 90(4):299-305. PubMed ID: 26340658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.